Pharma

Former Skyscanner Chief Technology Officer Dr Alistair Hann has joined NHS Scotland to help build a national digital platform aiming to improve access to information for both citizens and health and care staff and remove interoperability barriers.

23andMe on Wednesday announced that GlaxoSmithKline has invested $300 million to gain exclusive access to the genetic testing startup’s DNA database.

California-based telehealth provider InTouch Health inked a letter of intent alongside Rite Aid to explore how the virtual care platform can be implemented by the retail pharmacy chain to boost customers’ access to care.

As Johnson & Johnson continues to move out of the diabetes business, the company has sold its Calibra product (marketed as OneTouch Via, but never launched) to CeQur, a 10-year-old company working on a similar insulin-delivery wearable.

Pharma companies are getting more and more open about their digital health initiatives, which has given MobiHealthNews more opportunities this quarter than usual to chronicle pharma’s efforts around adherence, clinical trials, and the burgeoning world of digital therapeutics.

Medication management and adherence app maker Medisafe has announced a partnership with Boehringer Ingelheim following a successful pilot.

Submissions for speaking opportunities at the health IT conference are open until July 16, 2018.

The new Rosalind Franklin Institute is investing £6m in ground-breaking initiatives that will disrupt the drug development process.

Biogen has just launched a new app, called Aby, aimed at giving people living with multiple sclerosis (MS) accurate and reliable information about the condition and support.

Medidata, a New York City-based company that offers cloud storage and data analytics services for clinical trials, announced today that it has acquired Shyft Analytics, maker of a cloud data analytics platform specifically designed for the pharma and biotech industries.